Background: Immune checkpoint inhibitors (ICIs) have moved to the frontline in recent years to manage upper gastrointestinal (UGI) tumors, such as esophageal and gastric cancers. This retrospective review sheds light on real-world data on ICI-treated UGI tumors to identify risk factors (clinical and pathological) impacting the outcome other than traditional biomarkers (programmed cell death ligand 1 (PD-L1) or microsatellite instability status).
Methods: Patients with UGI tumors who received at least one dose of ICI for stage IV or recurrent disease between January 1, 2015, and July 31, 2021, at The Ohio State University were included in the study.
The rapid global adoption of electric vehicles (EVs) necessitates the development of advanced EV charging infrastructure to meet rising energy demands. In particular, community parking lots (CPLs) offer significant opportunities for coordinating EVs' charging. By integrating energy storage systems (ESSs), renewable energy sources (RESs), and building prosumers, substantial reductions in peak load and electricity costs can be achieved, while simultaneously promoting environmental sustainability.
View Article and Find Full Text PDFBackground: Early discharge planning is important for safe, cost-effective, and timely hospital discharges. Patients with deconditioning are at risk for prolonged lengths of stay related to discharge needs. Functional mobility outcome measures are associated with discharge disposition.
View Article and Find Full Text PDF